Delivery Order SPE2DB20D1100-SPE2DB24FD8K8

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical awarded to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of sucralfate 1 gram tablets, a pharmaceutical product used to treat digestive disorders. The delivery order has a ceiling value of $1,531.92 and is a firm fixed-price contract. The ultimate completion date for this order is September 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $24,503.59 firm fixed-price contract is for the delivery of 4,563,755,373 units of 1 gram sucralfate tablets, with a period of performance through February 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,339.02, is for the delivery of 4,563,250,149 units of Sucralfate 1 GM Tablet 90S, a medication used to treat certain stomach and esophagus problems. This is a firm fixed-price delivery order contract with a period of performance through January 8, 2024. The contract is not designated as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,500.49 firm-fixed-price contract is for the supply of Sucralfate 1 GM/10 ML Suspension, a medication used to treat and prevent certain types of ulcers. The contract has a completion date of September 26, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,535.22 firm fixed-price order is for 4,566,812,259 units of Sucralfate 1 GM/10 ML Suspension, a medication used to treat stomach and duodenal ulcers. The IDC has a ceiling value of $999,999,999 and runs through November 2026, serving as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,215.64 firm fixed-price delivery order contract is for the supply of Sucralfate 1 GM tablets, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of October 31, 2023 and does not have a set-aside designation, indicating open competition....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,065.16 fixed-price contract is for the supply of 4,562,853,079 tablets of the medication Sucralfate 1 gram. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) awarded a $4,456.25 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 420mL of Sucralfate 1 gram/10mL suspension. This order was placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. The IDC enables AmerisourceBergen to efficiently deliver a comprehensive range of pharmaceutical products and...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,044.82, is for the delivery of 420 ml bottles of 1 gram/10 ml sucralfate suspension. The award has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, with ID SPE2DB22D2006|SPE2DB24FV9UL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of sucralfate 1 gram tablets, with a ceiling value of $39,810.57 and a completion date of April 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD8K8
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,098.48 delivery order is for the supply of 90-count bottles of 1 gram Sucralfate tablets, a medication used to treat ulcers. The contract does not have a set-aside designation. As a key supplier to the U.S. federal government, AmerisourceBergen holds several high-value IDCs with the DLA and other agencies to provide a wide range of essential pharmaceutical products and medical supplies in support of military treatment facilities, veterans' healthcare, and other federal programs.

Generated 12/16/24, 2:41 PM